Richard MacIsaac
St Vincent's Hospital, VIC, Australia
- This delegate is presenting an abstract at this event.
 
      
        Richard MacIsaac is professor and director of Endocrinology and Diabetes at St Vincent’s Hospital and the University of Melbourne.  Prior to taking up his current position he was head of diabetes at Austin Health.  His main research interest is diabetes and its complications, especially those related to cardiovascular and kidney disease.  He has published over 170 research articles.  Prior to embarking in a career in medicine, he completed a PhD at the Howard Florey Institute, Melbourne where he examined the development of the foetal hypothalamic-pituitary-adrenal axis and then embarked on a 2-year post doctorial fellowship at St Vincent’s Institute of Medical Research, Melbourne examining foetal calcium metabolism.  He graduated from the University of Melbourne’s Medical School in 1995 and was awarded his fellowship with the Royal Australasian College of Physicians in 2002.  Currently specific research interests are inpatient glycaemic control, defining the albuminuria and glomerular filtration rate relationship in diabetes, investigating new biomarkers for renal and vascular disease in diabetes and studying renal function in indigenous Australians.      
      Presentations this author is a contributor to:
                  
          
          Evaluation of Closed Loop Performance in Adults with Type 1 Diabetes Undertaking Anaerobic Versus Aerobic Exercise: A Randomised Crossover Study (#82)
  
  8:45 AM
      
    Dilshani Jayawardene    
  
          
            
            ADS President's Clinical Young Investigator Award          
        
                        
          
          Trajectories of eGFR decline over a four year period: the eGFR Follow-up Study (#32)
  
  11:30 AM
      
    Federica Barzi    
  
          
            
            ADS Clinical Orals - Renal & Foot Complications          
        
                        
          
          Exercise capacity (VO2max) is reduced in Type 2 diabetes mellitus (T2DM) but not Type 1 (T1DM), and is not due to diastolic dysfunction (#141)
  
  5:15 PM
      
    Timothy J Roberts    
  
          
            
            ADS Clinical Orals - Pregnancy, diet & exercise          
        
                        
          
          Pulmonary microvascular disease in diabetes mellitus (DM) subjects detected by exercise echocardiography is not associated with reduced exercise capacity (#85)
  
  9:30 AM
      
    Timothy J Roberts    
  
          
            
            ADS President's Clinical Young Investigator Award          
        
                        
          
          Functional Magnetic Resonance Imaging (MRI) changes in Type 1 Diabetes with and without Renal Hyperfiltration (#221)
  
  2:00 PM
      
    Jas-mine Seah    
  
          
            
            ADS Clinical Poster Award Session          
        
                        
          
          The contribution of glycaemic status to the progression of kidney disease among Indigenous Australians with and without albuminuria– the eGFR follow-up study (#30)
  
  11:00 AM
      
    Elizabeth LM Barr    
  
          
            
            ADS Clinical Orals - Renal & Foot Complications          
        
                        
          
          Tumour Necrosis Factor-alpha Receptor 1 and 2 are Reduced in patients with Type 1 Diabetes and Hyperfiltration (#34)
  
  12:00 PM
      
    Jas-mine Seah    
  
          
            
            ADS Clinical Orals - Renal & Foot Complications          
        
                        
          
          Audit of Diabetes Management Guidelines for the Cancer Centre during the Pilot Phase (#59)
  
  4:15 PM
      
    Peter G Colman    
  
          
            
            ADS Clinical Orals - Type 2 Therapies          
        
                        
          
          Regulation of alpha cell function and fatty acid levels by hyperinsulinaemia after islet cell transplantation in Type 1 diabetes (#166)
  
  10:45 AM
      
    Glenn M Ward    
  
          
            
            ADS Clinical Orals - Type 1 Diabetes          
        
            
 ADS-ADEA 2016*
                ADS-ADEA 2016*